Part B Drug Payment Change: Understanding the Implications for Pharma, New Webinar Hosted by Xtalks


March 27, 2016 Facebook Twitter LinkedIn Google+ Press Releases


TORONTO, ON–(Marketwired – March 22, 2016) – The session coming up on Monday, March 28, 2016, featuring industry experts from Xcenda, including Amanda Forys, MSPH, Director of Reimbursement Policy Insights and Jennifer Snow, MPH, Director of Health Policy, will focus on what’s known about the proposed Medicare Part B drug payment model and what the implications are for pharmaceutical manufacturers. Additionally, the speakers will share strategies on how manufacturers will have to evolve to demonstrate product value.
Marketwired – Medical and Healthcare

Comments